Global Pulmonary Arterial Hypertension (PAH) Treatment Market Size to Touch USD 10.3 Billion by 2030
Global Pulmonary Arterial Hypertension (PAH) Treatment Market is thriving due to a rising prevalence of pulmonary hypertension, advancements in drug development, increasing awareness about the disease, improving healthcare infrastructure, and growing demand for effective therapies.